SEC Form 4 · accession 0001127602-18-026096
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Coyle
Officer — EVP & Group Pres, Cardiac&Vasc
Period of report
Aug 22, 2018
Accepted (ET)
Aug 23, 2018 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 22, 2018 | M | 23,175 | $43.15 | A | 190,680 | D | |
| Ordinary Shares | Aug 22, 2018 | M | 70,984 | $37.53 | A | 261,664 | D | |
| Ordinary Shares | Aug 22, 2018 | M | 84,060 | $34.88 | A | 345,724 | D | |
| Ordinary SharesF1 | Aug 22, 2018 | S | 145,544 | $95.498 | D | 200,180 | D | |
| Ordinary Shares | holding | — | — | — | 250 | I | By Family Trust | |
| Ordinary Shares | holding | — | — | — | 4,104 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $43.15 | Aug 22, 2018 | M | 23,175 | D | — | Feb 1, 2020 | Ordinary Shares | 23,175 | 0 | D |
| Stock Option (Right to Buy)F3 | $37.53 | Aug 22, 2018 | M | 70,984 | D | — | Aug 2, 2020 | Ordinary Shares | 70,984 | 0 | D |
| Stock Option (Right to Buy)F4 | $34.88 | Aug 22, 2018 | M | 84,060 | D | — | Aug 1, 2021 | Ordinary Shares | 84,060 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.365 to $95.665, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- F2This option to purchase 23,175 ordinary shares of New Medtronic for $43.15 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 23,175 Medtronic common stock shares for $43.15 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F3This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F4This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.